Lyell Immunopharma, Inc. - LYEL

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Aug 11, 2026 VP, Corporate Controller S D 621.0 14.34 8,905.14 14,799.0 View
Aug 11, 2026 Chief Scientific Officer S D 131.0 14.34 1,878.54 17,677.0 View
Aug 11, 2026 Chief Operating Officer S D 89.0 14.34 1,276.26 17,805.0 View
Aug 11, 2026 President and CEO S D 390.0 14.34 5,592.6 73,488.0 View
Jul 27, 2026 J D 44,000.0 0.0 0.0 2,774,980.0 View
Jul 27, 2026 J D 38,500.0 0.0 0.0 2,818,980.0 View
Jul 20, 2026 S D 10.0 13.7 137.0 2,857,480.0 View
Jul 17, 2026 S D 10.0 13.73 137.3 2,857,490.0 View
Jul 01, 2026 J D 76,000.0 0.0 0.0 2,857,500.0 View
Jun 18, 2026 J D 66,500.0 0.0 0.0 2,933,500.0 View
Jun 15, 2026 Chief Scientific Officer S D 130.0 18.92 2,459.6 17,808.0 View
Jun 15, 2026 Chief Operating Officer S D 89.0 18.92 1,683.88 17,894.0 View
Jun 15, 2026 VP, Corporate Controller S D 217.0 18.91 4,103.47 15,420.0 View
Jun 15, 2026 President and CEO S D 388.0 18.91 7,337.08 73,878.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 12, 2026 A A 9,250.0 0.0 0.0 9,250.0 View
Jun 11, 2026 Chief Medical Officer S D 1,977.0 12.64 24,989.28 20,923.0 View
Mar 16, 2026 Chief Fin. and Bus. Officer A A 140,000.0 0.0 0.0 140,000.0 View
Mar 09, 2026 P A 488,090.0 25.61 12,499,984.9 1,426,528.0 View
Mar 09, 2026 P A 488,090.0 25.61 12,499,984.9 1,426,528.0 View